AMAbdelrhani Mokhtari

Abdelrhani Mokhtari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdelrhani Mokhtari has a total of 172 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Research cartography of implantable medical devices in the three Maghreb countries: A comparative study between Morocco, Algeria, and Tunisia

    by Meryem Qouhafa, Brahim Benaji, Souad Lebbar, Asmae Marrakechi, Abdelmajid Soulaymani, Benayad Nsiri, My Hachem El Yousfi Alaoui, Mokhtari Abdelrhani, Mohammed Azougagh

  • Open Access

    Adverse drug reactions of anti-infective drugs for systemic use in Morocco: Pharmaco-Epidemiological study 2008-2016

    by Donia Kharbouch, Houda Sefiani, Zineb Nabih, Sanou Khô Coulibaly, Tidiane Diallo, Abdelmajid Soulaymani, Abdelrhani Mokhtari, Rachida Soulaymani Bencheikh

    Analyzing the spontaneous reports of adverse drug reactions (ADRs) of anti-infective drugs for systemic use is an essential pillar in creating valuable database in pharmacovigilance.Therefore, the main of this study is to describe the epidemiological and clinical properties, as well as, the frequency and profile of ADRs generated by anti-infective treatment, declared at the Moroccan Anti-Poison and Pharmacovigilance Center (MAPPC).A retrospective descriptive study was implemented from the notifications of ADRs generated between 2008 and 2016 and recorded on VIGIBASE. Over the research period, 1161 cases of ADRs reports were declared. The average age was 37.4 years ± 19.52, it’s been noticed that the adults were the most affected in 81.89% of the total cases, with the sex ratio (Female / Male) being 1.34. Antimycobacterials and antibacterials for systemic use were responsible for 68% and 28.3% of the adverse reactions, respectively. 29.76% of the cases showcased skin and subcutaneous tissue disorders and 23.23% of the cases displayed hepatobiliary and pancreatic system disorders. Serious cases represented 30% of all noted cases, including 2 fatalities. In the interest of preventing the risk of adverse reactions originating from the taking anti-infective drugs for systemic use, reporting to the ADRs to the pharmacovigilance system should be highly encouraged.


  • Open Access

    Vigilance towards the use of artificial intelligence applications for breast cancer screening and early diagnosis

    by Younes El Ouahabi, My Hachem El Yousfi Alaoui, Benayad Nsiri, Abdelmajid Soulaymani, Abdelrhani Mokhtari, Brahim Benaji

    Breast cancer is a real public health problem in Morocco. It is the cause of a significant number of deaths caused by late diagnosis. Mammography plays an essential role in the detection of breast cancer and in the early management of its treatment. Despite the existence of screening programs, there are still high rates of false positives and false negatives. Indeed, women were called back for additional diagnoses based on suspicious results that eventually led to cancer. Artificial intelligence (AI) algorithms represent a promising solution to improve the accuracy of digital mammography offering, on the one hand, the possibility of better cancer detection, and, on the other hand, improved efficiency for radiologists for good decision-making.In this work, through a review of the literature on the tools used to evaluate the performance of AI systems dedicated to early detection and diagnosis of breast cancer. We set out to answer the following questions: Is the ethics relating to patient data during the development phase of this software is respected? Do these tools take into consideration the specificities of the field? What about the specification, accuracy and limitations of these applications?At the end, we show through this work recommendations to adapt these evaluation tools of AI applications for breast cancer screening for an optimized and rational consideration of the principle of health vigilance and compliance with the regulatory standards in force governing this field.


  • Étude rétrospective des effets indésirables du vaccin BCG chez l’enfant de moins de quatre ans

    by S. Belamalem, A. Tebaa, A. Khadmaoui, Mokhtari Abdelrhani, Soulaymani Abdelmajid, R. Soulaymani-Bencheik

  • Open Access

    Development and Validation of a Questionnaire on Pharmacovigilance Knowledge among Health Professionals in Morocco

    by Zakaria Abidli, Sara Jadda, Salma Ammor, Abdelmajid Soulaymani, Abdelrhani Mokhtari, Rachida Soulaymani Bencheikh, Hinde Hami

    Background: Pharmacovigilance is one of the priority programs of the World Health Organization, with the aim of detecting the adverse effects of drugs. Morocco is one of the countries open to the world and was the first Arab and African country to participate in the international pharmacovigilance program. The purpose of this study is to develop and to validate a reliable and reasonable questionnaire, to measure knowledge and practices related to pharmacovigilance among health professionals in Morocco. Materials and Methods: This is a cross-sectional study that took place between January and March 2018. The study was based on a questionnaire. Pharmacovigilance experts validated the questionnaire and the final instrument was applied to health professionals practicing in different hospitals in Morocco. The statistical validation of the questionnaire is based on the calculation of the Cronbach Coefficient Index and a factor analysis. Results: The study involved 262 health professionals, including 39% of physicians, 35% of pharmacists and 26% of nurses. The average age of the participants was 35.2 ± 8.4 years old. The Cronbach alpha value of the set of items was 0.7, similarly, the calculation of Cronbach’s alpha showed a homogeneity of the different dimensions of the questionnaire used this for knowledge (α = 0.6) and practices related to pharmacovigilance (α = 0.6). On the knowledge side, 65% of participants correctly answered the definition of pharmacovigilance, 81% were aware of its primary objective. We have noted that 52% of health workers, were aware of the existence of a national pharmacovigilance program in Morocco and 71% of the existence of the poison control center and pharmacovigilance of Morocco. The questionnaire has also shown that 28% of participants have reported an adverse reaction to the Poison Control and Pharmacovigilance Center of Morocco. Conclusion: Results showed that questionnaire is a well-structured, objective, valid and reliable in the Moroccan context, the questionnaire could be an instrument to assess knowledge and practice in Pharmacovigilance. Key words: Validation, Questionnaire, Pharmacovigilance, Health Professionals, Morocco.


  • Open Access

    Gallbladder cancer in Morocco: the epidemiological evidence

    by A. Haimer, F. Habib, A. Soulaymani, A. Mokhtari, H. Hami

    Introduction: Gallbladder cancer is the 22nd most common cancer in men and women and the 16th leading cause of cancer-related death in Northern Africa, with an estimated 2 479 new cases of gallbladder cancer (1 568 women and 911 men) and 2 313 cancer deaths in 2012 (GLOBOCAN 2012). This study was conducted to determine the prevalence and epidemiological characteristics of gallbladder cancer in Morocco.

  • The Evaluation of Burnout Syndrome among health professionals in Casablanca, Rabat and Kenitra

    by Zakaria Abidli, Sara Jadda, Donia Kharbouch, Aicha Detsouli, Abdelrhani Mokhtari, Asmaa Zaidouni, Abdelmajid Soulaymani


  • Open Access

    Cases of Adverse Drug Events in pediatrics: Prospective Study at a Hospital in Rabat (Morocco)

    by Laila Torissi, Soulaymani A. Soulaymani, Mokhtari A. Mokhtari, Soulaymani R. Soulaymani

    Pharmacovigilance aims to guarantee the safe use of medicines. It is based on the reporting of adverse effects by health professionals, industry and the public. Pharmacovigilance is the monitoring of drugs and the prevention of the risk of adverse effects resulting from their use, whether this risk is potential or proven. It relies on the spontaneous reporting of adverse events by health professionals and patients, the collection of adverse effects for the detection of signals the establishment of preventive measures. Many studies have highlighted the importance of harm related to Adverse Drug Events especially in children. In connection with this, we carried out a study of the undesirable effects of medicines at the Children’s Hospital of Rabat. This study was authorized by the Ministry of Health and lasted 6 months during which were recollected several cases including 10 cases presented in this article.


  • EPID-15. CHILDHOOD BRAIN TUMORS IN MOROCCO AN 11-YEAR RETROSPECTIVE STUDY

    by Amal Haimer, Faouzi Habib, Abdelmajid Soulaymani, Abdelrhani Mokhtari, Hinde Hami

    This study was conducted to determine the epidemiological aspects of pediatric brain tumors in Morocco. This is a descriptive retrospective study of children with brain tumors, diagnosed and treated at Al Azhar Oncology Center in Rabat between 2005 and 2015. During the study period, 10 children under the age of 15 years were diagnosed with brain tumors at Al Azhar Oncology Center, accounting for 8.7% of all cancers in children collected during this period. Nearly two-thirds of the cases (60%) were boys with a male-female ratio of 1.5. The average age of diagnosis was 7.6 ± 3.3 years (range 3-13). One-half of the cases were diagnosed in children aged 5-9 years (50%). Among the cases for whom the outcome was known, a 13-year-old girl died during the study period. Although rare, cancer in children has a substantial impact on public health in Morocco. A national cancer registry will assist in better planning, resource allocation and management including psychosocial support to improve the quality of life of childhood cancer survivors and their families.

  • Open Access

    Pancreatic cancer in Morocco: A retrospective review

    by A. Haimer, F. Habib, A. Soulaymani, A. Mokhtari, H. Hami

    Introduction: Pancreatic cancer is an uncommon and aggressive cancer in Northern Africa. It is the 14th most commonly diagnosed cancer in men and women and the 11th leading cause of cancer-related death, with about 4 034 new cases of pancreatic cancer and 3 915 cancer deaths estimated to have occurred in 2012 (GLOBOCAN 2012). The aim of this study is to determine the epidemiological profile of pancreatic cancer in Morocco.